35%
GSH Increase
6-month RCT, high-dose
⚠️ FOR RESEARCH PURPOSES ONLY — This compound is not FDA approved. All data presented is from clinical trials for educational reference.

Antioxidant & Detoxification Peptide
A 3-amino acid tripeptide (γ-Glu-Cys-Gly) that serves as the body's primary endogenous antioxidant, neutralizing reactive oxygen species and supporting cellular detoxification pathways in research models. Premium Research Peptide.
35%
GSH Increase
6-month RCT, high-dose
2×
NK Cell Activity
Immune function boost
500+reactions
Cellular Processes
Essential cofactor
3amino acids
Tripeptide
Glu-Cys-Gly
54subjects
Landmark RCT
6-month clinical trial
GSH directly scavenges free radicals and reactive oxygen species. The enzyme glutathione peroxidase uses GSH to detoxify hydrogen peroxide and lipid peroxides, protecting cell membranes and DNA from oxidative damage.
Glutathione S-transferases (GSTs) conjugate GSH to toxins, drugs, and carcinogens, making them water-soluble for elimination. This is the body's primary mechanism for removing harmful compounds from cells.
GSH maintains cellular redox balance by cycling between reduced (GSH) and oxidized (GSSG) forms. The GSH/GSSG ratio is a key indicator of cellular health and oxidative stress status.
Key insight: A healthy GSH/GSSG ratio protects against oxidative damage and supports optimal cellular function
Human studies on glutathione supplementation
Increase in Blood GSH Levels at 6 Months (High Dose)
Key finding: This was the first trial to demonstrate that daily oral GSH supplements effectively increase body compartment stores of glutathione in humans. Effects were dose-dependent and returned to baseline after washout.
First long-term RCT demonstrating oral GSH bioavailability in humans
Important: Both doses were effective, with the 1000mg dose showing greater and faster increases. Effects were sustained throughout the 6-month period.
Documented effects from scientific studies
NK cell activity
SourceCellular stores
SourceALT improvement
SourceBrightness support
SourceGlutathione is the body's primary water-soluble antioxidant, directly neutralizing free radicals and regenerating other antioxidants
GSH supplementation significantly enhanced NK cell cytotoxicity, a key marker of innate immune function
Research note: NK cells are critical for eliminating virus-infected and tumor cells
Oral GSH improved whole-body insulin sensitivity in obese subjects with and without type 2 diabetes
From clinical trial protocols
Oral glutathione dosing in clinical trials has ranged from 250mg to 1000mg daily. Higher doses showed greater and faster increases in tissue GSH levels.
Based on landmark 6-month RCT
250-500mg
Once or twice daily
Lower dose for general support
1000mg
Divided doses
Higher dose for maximum effect
Take on empty stomach for best absorption
Effects accumulate over 1-6 months
Consider liposomal forms for enhanced bioavailability
Benefits return to baseline within 1 month of stopping
For direct delivery
600-1200mg
IV push or slow infusion
Bypasses digestive system
As directed
Weekly to monthly
Based on individual needs
IV administration provides 100% bioavailability
Should be administered by qualified healthcare providers
FDA has noted safety concerns with compounded IV GSH
Consider oral/liposomal alternatives for maintenance
Oral GSH was previously thought to be poorly absorbed
Recent trials demonstrate effective oral bioavailability
Liposomal formulations may enhance absorption
Generally well-tolerated in clinical trials
Oral glutathione supplementation has demonstrated an excellent safety profile in clinical trials lasting up to 6 months. Most studies report minimal to no adverse effects.
IV glutathione has different safety considerations than oral supplementation
No participants discontinued due to adverse effects in major trials
Both oral doses (250mg and 1000mg) were well tolerated
IV glutathione is not FDA-approved for any indication
Skin lightening use of IV GSH raises safety concerns
Long-term safety of high-dose oral GSH not fully established
Pregnancy/breastfeeding safety data is limited
Chemical and structural properties
The body's master antioxidant tripeptide
Essential cofactor for multiple enzyme families
Proper handling and storage
Common questions about glutathione research
Glutathione (GSH) is a tripeptide composed of glutamate, cysteine, and glycine that's found in every cell of the body. It's called the 'master antioxidant' because it directly neutralizes free radicals, regenerates other antioxidants (vitamins C and E), and is essential for the body's detoxification systems. GSH participates in over 500 enzymatic reactions and maintains cellular redox balance.
Yes. While it was previously believed that oral GSH was poorly absorbed, a landmark 6-month randomized controlled trial demonstrated that daily oral GSH supplementation (250-1000mg) significantly increased glutathione levels in blood, erythrocytes, plasma, lymphocytes, and buccal cells. The high-dose group showed 30-35% increases in most compartments and a remarkable 260% increase in buccal cells. These findings confirmed oral GSH bioavailability in humans.
Clinical trials have demonstrated several benefits: (1) Increased tissue glutathione stores by 30-260% depending on tissue type; (2) More than doubled Natural Killer cell cytotoxicity, indicating enhanced immune function; (3) Improved insulin sensitivity in obese subjects with and without diabetes; (4) Reduced skin melanin indices in multiple body sites; (5) Decreased liver enzymes (ALT) in NAFLD patients. Benefits were dose-dependent and accumulated over time.
Clinical trials have used doses ranging from 250mg to 1000mg daily. The 6-month RCT showed that both doses were effective, but 1000mg produced greater and faster increases in tissue GSH levels. Benefits were seen by 1 month and continued to increase through 6 months. Some protocols divide the daily dose into two administrations. Liposomal formulations may enhance absorption at lower doses.
Oral glutathione has demonstrated an excellent safety profile in clinical trials lasting up to 6 months. In the landmark RCT, 100% of participants completed the study with no dropouts due to adverse effects. Both low-dose (250mg) and high-dose (1000mg) were well-tolerated. However, IV glutathione has different safety considerations — the FDA has received adverse event reports with compounded IV GSH, and it's not approved for any indication including skin lightening.
Clinical trials showed measurable increases in tissue glutathione levels within 1 month of supplementation, with continued improvements through 6 months. NK cell cytotoxicity more than doubled by 3 months in the high-dose group. Importantly, when supplementation stopped, levels returned to baseline within 1 month — indicating that ongoing supplementation is needed to maintain elevated GSH stores.
Glutathione is the direct antioxidant molecule, while NAC is a precursor that provides cysteine (the rate-limiting amino acid for GSH synthesis). NAC has extensive clinical data and supports the body's own GSH production. Direct GSH supplementation has the advantage of not requiring metabolic conversion, but NAC has better-established long-term safety data. Some practitioners use both approaches.
A randomized, placebo-controlled trial found that oral GSH (500mg/day for 4 weeks) decreased melanin indices at all six measured body sites, with statistically significant reductions on the face and sun-exposed forearm. However, the researchers noted that long-term safety for this use hasn't been established. IV glutathione for skin lightening is NOT recommended due to safety concerns flagged by the FDA and other regulatory bodies.
Peer-reviewed research
Richie JP Jr, Nichenametla S, Neidig W, et al.
Arjinpathana N, Asawanonda P
Søndergård SD, Cintin I, Kuhlman AB, et al.
Honda Y, Kessoku T, Sumida Y, et al.
Wu G, Fang YZ, Yang S, et al.
Sinha R, Sinha I, Calcagnotto A, et al.
Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.
Antioxidant & cellular health support